BusinessAquinox Announces Closing of $75.4 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesBy Nasdaq OMXSep 23, 2016, 5:15 PM UTC
BusinessApricus Biosciences Announces $4.6 Million Registered Direct OfferingBy Nasdaq OMXSep 23, 2016, 12:00 PM UTC
BusinesspSivida to Present at the Ladenburg Thalmann Annual Healthcare ConferenceBy Nasdaq OMXSep 22, 2016, 1:01 PM UTC
BusinesspSivida to Present at the Ladenburg Thalmann Annual Healthcare ConferenceBy Nasdaq OMXSep 22, 2016, 1:01 PM UTC
BusinessApricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by RecordatiBy Nasdaq OMXSep 21, 2016, 11:00 AM UTC
BusinessApricus Biosciences Announces Completion of Transfer of the Marketing Authorizations for Vitaros® in Finland and Denmark to Ferring PharmaceuticalsBy Nasdaq OMXSep 20, 2016, 11:01 AM UTC
BusinessCatalyst Pharmaceuticals Announces Publication of CPP-115 Clinical Efficacy Data for Infantile Spasms in Epilepsy & Behavior Case ReportsBy Nasdaq OMXSep 19, 2016, 12:03 PM UTC
BusinessFibrocell Completes Enrollment in NC1+ Cohort of Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXSep 19, 2016, 12:00 PM UTC
